Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$253.85 - $299.46 $964,630 - $1.14 Million
3,800 Added 135.71%
6,600 $1.98 Million
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $293,194 - $332,673
1,100 Added 64.71%
2,800 $765,000
Q2 2023

Aug 14, 2023

BUY
$271.49 - $305.09 $217,192 - $244,071
800 Added 88.89%
1,700 $518,000
Q1 2023

May 15, 2023

SELL
$246.13 - $285.47 $147,678 - $171,282
-600 Reduced 40.0%
900 $256,000
Q4 2022

Feb 14, 2023

BUY
$205.51 - $253.93 $308,265 - $380,895
1,500 New
1,500 $0

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.